World

Biomatter raises $18M Series A to expand AI enzyme design operations in Vilnius

١٣‏/١١‏/٢٠٢٦

Biomatter closes an $18M Series A led by Astanor to build a new AI enzyme design facility in Vilnius and expand its US commercial presence.